We are live on ! Find out more
VMD icon

Viemed Healthcare

76 hedge funds and large institutions have $104M invested in Viemed Healthcare in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

5% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 22

5% less capital invested

Capital invested by funds: $109M → $104M (-$5.19M)

5.69% less ownership

Funds ownership: 55.28%49.59% (-5.7%)

14% less funds holding

Funds holding: 8876 (-12)

37% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 27

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
76
Holders Change
-12
Holders Change %
-13.64%
% of All Funds
1.28%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
17
Increased
23
Reduced
22
Closed
27
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$783K +$203K +37,644 +35%
AA
27
Ancora Advisors
Ohio
$743K
Los Angeles Capital Management
28
Los Angeles Capital Management
California
$699K -$410K -76,111 -37%
LPL Financial
29
LPL Financial
California
$632K +$73.3K +13,600 +13%
PCMI
30
Paradigm Capital Management Inc
New York
$622K +$84.5K +15,667 +16%
Connor, Clark & Lunn Investment Management (CC&L)
31
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$599K +$404K +75,000 +210%
PCM
32
Pinz Capital Management
New York
$583K +$584K +108,320 New
VCP
33
Verus Capital Partners
Arizona
$491K -$378K -70,189 -77%
OAM
34
Oppenheimer Asset Management
New York
$465K -$11K -2,048 -2%
RC
35
RBF Capital
California
$430K +$431K +80,000 New
CCIA
36
Campbell & Co Investment Adviser
Maryland
$383K +$384K +71,230 New
MFG
37
Merit Financial Group
Georgia
$264K +$265K +49,146 New
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$248K +$188K +34,846 +312%
JC
39
JBF Capital
Colorado
$236K
Osaic Holdings
40
Osaic Holdings
Arizona
$161K
Two Sigma Investments
41
Two Sigma Investments
New York
$158K +$48.6K +9,008 +44%
Qube Research & Technologies (QRT)
42
Qube Research & Technologies (QRT)
United Kingdom
$158K +$159K +29,431 New
JF
43
Jump Financial
Illinois
$145K +$145K +26,900 New
BA
44
BCM Advisors
Louisiana
$131K
William Blair & Company
45
William Blair & Company
Illinois
$124K
BA
46
Bard Associates
Illinois
$112K +$16.2K +3,000 +17%
Geode Capital Management
47
Geode Capital Management
Massachusetts
$104K -$1.58M -293,194 -94%
Bank of America
48
Bank of America
North Carolina
$102K -$61.6K -11,421 -38%
CSS
49
Cubist Systematic Strategies
Connecticut
$93K +$93.7K +17,378 New
LCM
50
Laurion Capital Management
New York
$86K +$85.9K +15,927 New

VMD Hedge Fund Activity: Q2 2022 in Review

76 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q2 2022, worth a combined $104M — down 4.7% from $109M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of VMD and 17 opened new positions — a net loss of 10 holders — while 22 trimmed existing stakes and 23 added.

The largest buyer was Wasatch Advisors, adding an estimated $6.74M. The largest seller was BlackRock, cutting an estimated $7.08M.

  • 76 institutional investors held Viemed Healthcare (VMD) as of Q2 2022, down from 88 in Q1 2022.
  • Funds reported $104M of Viemed Healthcare stock for Q2 2022, down 4.7% quarter-over-quarter.
  • 17 funds opened new Viemed Healthcare positions in Q2 2022 and 27 closed out, a net change of -10 holders.
  • The largest Viemed Healthcare buyer in Q2 2022 was Wasatch Advisors, an estimated $6.74M added.
  • The largest Viemed Healthcare seller in Q2 2022 was BlackRock, an estimated $7.08M sold.

Based on aggregated 13F filings for Q2 2022.